Buscar
01/09/2024
Prognostic Value of Hyperuricemia in Developing Cardiovascular Events in Patients with Chronic Inflammatory Arthritis: A 10-Year Prospective Study
Avil s, A, Plaza, Z, S nchez-Alonso, F, Casta eda, S, Fernandez-Gutierrez, B, D az, C, Font, P, Martinez, O, Giner, E, Senabre, JM, Rueda, A, Perez, A, Sanchez, G, Gonzalez, C, Garc a, J, Llorca, J, Gonzalez-Gay, MA, Andres, M. Prognostic Value of Hyperuricemia in Developing Cardiovascular Events in Patients with Chronic Inflammatory Arthritis: A 10-Year Prospective Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients
Escudero, PG, G mez, MLI, L pez, BM, Santos, DD, de Miera, FJTS, Dorta, AG, Beriain, JAH, R a-Figueroa, I, Santos, CS, Alvarez, ED, Mart nez, MI, Frade-Sosa, B, Urgelles, JF, Lizarzaburu, MS, Alonso, ER, Aragu s, ET, Merayo, EE, Rodriguez-Laguna, M, Monjo, I, Merino, C, Vela-Casasempere, P, G mez, IV, Filloy, JAM, Melero-Gonzalez, RB, Belando, CG, Boselli, G, Boteanu, AL, Su rez, DVF, Selaya, CC, Roman, AMR, Calvo-Al n, J. Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
The Gut-Airways Microbiome axis in COPD
Viglino, J, Perea, L, Garcia-Nuñez, M, Rodrigo-Troyano, A, Torrego, A, Domínguez, M, Miratlles, L, Quero, S, Willis, J, Saus, E, Gabaldón, T, Gea, J, Santos, MS, Agusti, A, Monsó, E, Sibila, O, Faner, R. The Gut-Airways Microbiome axis in COPD. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3032. PMID:. IF:21.000(Q1/1D).
01/09/2024
Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC
Rink, S, Freeman, A, Bansal, AT, Bossios, A, Frankemoelle, B, Schleich, F, Sont, JK, Singh, M, Bieksiene, K, Bourdin, A, Canonica, GW, Csoma, Z, Gemicioglu, B, Grisle, I, Popovic, SG, Hromis, S, Korn, S, Kuna, P, Loureiro, C, Mihaltan, F, Porsbjerg, C, Ramos-Barbon, D, Renaud, L, Sergejeva, S, Ten Brinke, A, Yasinska, V, Zervas, E, Skrgat, S, Kurukulaaratchy, R. Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1763. PMID:. IF:21.000(Q1/1D).
01/09/2024
Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma
Fouka, E, Bansal, AT, Jaun, F, Håkansson, KEJ, Bieksiene, K, Bourdin, A, Butler, M, Canonica, GW, Csoma, Z, Dahlén, B, Gemicioglu, B, Grisle, I, Heaney, L, Heffler, E, Hromis, S, Kuna, P, Leuppi, J, Louis, R, Oureiro, C, Lúoviksdóttir, D, Mihaltan, F, Popovic, SG, Ramos-Barbon, D, Sedlak, V, Sergejeva, S, Skrgat, S, Ten Brinke, A, Yasinska, V, Zervas, E, Schleich, F, Porsbjerg, C, Bossios, A. Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA4008. PMID:. IF:21.000(Q1/1D).
01/09/2024
European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC
Rink, S, Freeman, A, Bansal, AT, Bossios, A, Frankemölle, B, Schleich, F, Sont, JK, Singh, M, Bieksiene, K, Bourdin, A, Canonica, GW, Csoma, Z, Gemicioglu, B, Grisle, I, Popovic, SG, Hromis, S, Korn, S, Kuna, P, Loureiro, C, Mihaltan, F, Porsbjerg, C, Ramos-Barbon, D, Renaud, L, Sergejeva, S, Ten Brinke, A, Yasinska, V, Zervas, E, Skrgat, S, Kurukulaaratchy, R. European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2149. PMID:. IF:21.000(Q1/1D).
01/09/2024
Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study
Jaun, F, Bánsal, AT, Fouka, E, Hakansson, KEJ, Bieksiene, K, Bourdin, A, Butler, M, Canonica, GW, Csoma, Z, Dahlén, B, Gemicioglu, B, Grisle, I, Heaney, L, Heffler, E, Hromis, S, Kuna, P, Mihaltan, F, Leuppi, JD, Loureiro, C, Louis, R, Luoviksdóttir, D, Ramos-Barbon, D, Popovic, SG, Samitas, K, Sedlak, V, Sergejeva, S, Skrat, S, Ten Brinke, A, Yasinska, V, Zervas, E, Schleich, F, Porsbjerg, C, Bossios, A. Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1248. PMID:. IF:21.000(Q1/1D).
01/09/2024
The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries
Bourdin, A, Bansal, AT, Di Matteo, S, Giacomo, CM, Heaney, B, Ten Brinke, A, Csoma, Z, Dahlen, B, Djukanovic, R, Heaney, L, Kuna, P, Heffler, E, Louis, R, Porsbjerg, C, Ramos-Barbon, D, Skrgat, S, Paulsson, T, Mascialino, B. The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1176. PMID:. IF:21.000(Q1/1D).
01/09/2024
Stoma Stent in a traqueotomy decanulation process. Experience in a cohort of patients with prolongued mechanical ventilation
Otero, ARP, Pujal, P, Rafecas, A, Panadero, C, Penacoba, P, Puy, C, Segura, M, Anton, PA. Stoma Stent in a traqueotomy decanulation process. Experience in a cohort of patients with prolongued mechanical ventilation. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2615. PMID:. IF:21.000(Q1/1D).
01/09/2024
Real-world effectiveness of switching to Benralizumab in patients with severe asthma in the Catalan population. Catalan Society of Pulmonology (SOCAP) Registry
Arismendi, E, Muñoz, M, Crespo, A, Ausin, P, Castillo, JA, Curto, E, Lapuente, A, Arguedas, AM, Martínez-Rivera, C, Monserrate, D, Muñoz, X, Ojanguren, I, Palones, E, Paredes, M, Pilia, F, Picado, C, Sabater, G, Sabadell, C, Sogo, A, Cañete, C. Real-world effectiveness of switching to Benralizumab in patients with severe asthma in the Catalan population. Catalan Society of Pulmonology (SOCAP) Registry. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3926. PMID:. IF:21.000(Q1/1D).
01/09/2024
Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective
Pinilla, L, Dodani, K, Benitez, I, Esmaeli, N, Gracia-Lavedán, E, Torres, G, Minguez, O, Martinez, D, Martínez-García, MA, Abad, J, Masdeu, MJ, Mediano, O, Muñoz, C, Cabriada, V, Duran-Cantolla, J, Mayos, M, Coloma, R, Montserrat, JM, De la Peña, M, Cano-Pumarega, I, Barbé, F, Azarbarzin, A, Sanchez-De-la-Torre, M. Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2693. PMID:. IF:21.000(Q1/1D).
01/09/2024
Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study
Gessner, C, Bogoevska, V, Nachtigall, D, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Criée, CP, Trinkmann, F. Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2121. PMID:. IF:21.000(Q1/1D).
01/09/2024
Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study
Greulich, T, Bogoevska, V, Nachtigall, D, Russell, R, Suppli, C, Wolfgang, U, Pohl, W, Plaza, V, Bourdin, A, Baumeister, S, Gessner, C. Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3907. PMID:. IF:21.000(Q1/1D).
01/09/2024
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
Rodriguez-Vida, A, Valderrama, BP, Castellano, D, Pinto, A, Mellado, B, Puente, J, Climent, MA, Domenech, M, Vazquez, F, Perez-Gracia, JL, Bonfill, T, Morales-Barrera, R, Gonzalez-Billalabeitia, E, Garcia-del-Muro, X, Maroto, P, Navarro-Gorro, N, Juanpere, N, Juan, O, Bellmunt, J. Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study. ESMO Open. 2024; 9(9)DOI:10.1016/j.esmoop.2024.103690. PMID:39214051. IF:8.300(Q1/2D).
01/09/2024
ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
Barba, A, López-Vilaró, L, Ferre, M, Majem, M, Martinez-Recio, S, Bell, O, Arranz, MJ, Salazar, J, Sullivan, I. ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer. Pharmaceutics. 2024; 16(9)DOI:10.3390/pharmaceutics16091121. PMID:39339159. IF:5.500(Q1/1D).
01/09/2024
Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series
Prat, A, Piñol, D, Espadaler, I, Campazas, I, Espinosa, I, Fusté, V, Szafranska, J, Fumagalli, C. Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series
Prat, A, Di Muro, MA, Acosta, SF, Vazquez, T, Rosell, SB, Orellana, R, Fumagalli, C. NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor
Carrillo-García, J, Hindi, N, Conceicao, M, Sala, MA, Ugalde, A, López-Pousa, A, Bagué, S, Sevilla, I, Vicioso, L, Ramos, R, Martínez-Trufero, J, Mateo, MCG, Cruz, J, Hernández-León, CN, Redondo, A, Mendiola, M, García, JM, Hernández, JE, Alvarez, R, Agra, C, de Juan-Ferré, A, Valverde, C, Cano, JM, de Sande, LM, Pérez-Fidalgo, JA, Lavernia, J, Marcilla, D, Gutiérrez, A, Moura, DS, Martín-Broto, J. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor. EUROPEAN JOURNAL OF CANCER. 2024; 209DOI:10.1016/j.ejca.2024.114270. PMID:39142211. IF:7.100(Q1/2D).
01/09/2024
Voice Outcome After Carbon Dioxide Transoral Laser Microsurgery for Glottic Cancer According to the European Laryngological Society Classification of Cordectomy Types – A Systematic Review
Sjogren E., Hendriksma M., Piazza C., Hartl D.M., Suarez C., Cohen O., de Bree R., Quer M., Poorten V.V., Rodrigo J.P., Civantos F., Genden E., Kowalski L.P., Makitie A., Shaha A., Takes R.P., Sanabria A., Guntinas-Lichius O., Rinaldo A., Ferlito A.. Voice Outcome After Carbon Dioxide Transoral Laser Microsurgery for Glottic Cancer According to the European Laryngological Society Classification of Cordectomy Types – A Systematic Review. JOURNAL OF VOICE. 2024; 38(5)DOI:10.1016/j.jvoice.2022.03.003. PMID:35422356. IF:2.400(Q1/1D).
01/09/2024
HPV-associated multiphenotypic sinonasal carcinoma. Tumour with indolent behaviour? A case-control study
Ballús, DP, López, L, Bagué, S, Gonzalez, A, Holgado, A, Gras, JR, Szafranska, J. HPV-associated multiphenotypic sinonasal carcinoma. Tumour with indolent behaviour? A case-control study. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
Sinonasal hamarthomas: a rare entity with a challenging diagnosis - how an accurate diagnosis impacts clinical and therapeutic management
Vilaró, LL, Prat, A, Piñol, D, Catasús, L, Rosell, SB, Casasayas, M, Cabrerizo, JRG, Szafranska, J. Sinonasal hamarthomas: a rare entity with a challenging diagnosis - how an accurate diagnosis impacts clinical and therapeutic management. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study
Bobes, A, Tormo, M, Diaz-Beya, M, Beneit, P, Botella, C, Moreno, AF, Mayol, AS, Sangerman, MA, Bermejo, AY, Amigo, MD, Labrador, J, Guinon, AG, Garrido, A, Serrano, J, Polo, SV, Fortes, MG, Sayas, MJ, Bergua, JM, Olave, MT, Vall-Llovera, F, Bargay, J, Sanchez, MP, Boyero, RG, Diaz-Lopez, A, de la Fuente, A. Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study. Clinical Lymphoma Myeloma & Leukemia. 2024; 24DOI:. PMID:. IF:2.700(Q2/4D).
01/09/2024
Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria
Kirkegaard-Biosca, C, del Barrio-Tofiño, E, Villamarín, M, Larrosa, N, Campany, D, González-López, JJ, Ferrer, R, Viñado, B, Doménech, L, Sellarès-Nadal, J, Escolà-Vergé, L, Fernández-Hidalgo, N, Los-Arcos, I. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics-Basel. 2024; 13(9)DOI:10.3390/antibiotics13090874. PMID:39335047. IF:4.600(Q1/2D).
01/09/2024
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles
Parladé, E, García-Leon, A, Voltà-Durán, E, Unzueta, U, Mangues, R, Casanova, I, Villaverde, A, Váquez, E. Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2024; 202DOI:10.1016/j.ejpb.2024.114410. PMID:39004320. IF:4.300(Q1/2D).
01/09/2024
Overview of Thigh and Leg Anatomical and Sonographic Landmarks in Rheumatic Patients
Balius, R, Pedret, C, Estrada-Alarcón, P, Corominas, H. Overview of Thigh and Leg Anatomical and Sonographic Landmarks in Rheumatic Patients. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2022.21131. PMID:36052637. IF:(Q/D).
01/09/2024
A re-assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight
Mercader-García, P, Silvestre, JF, Navarro-Triviño, FJ, Giménez-Arnau, AM, Pastor-Nieto, MA, Cordoba-Guijarro, S, Melé-Ninot, G, Tous-Romero, F, González-Pérez, R, Ruiz-González, I, Sánchez-Pérez, J, Gática-Ortega, ME, Sánchez-Pedreño, P, Miquel-Miquel, J, Ortiz-Frutos, J, Carrascosa, JM, Serra-Baldrich, E, Sanz-Sanchez, T, Soria-Aledo, V, Carrillo, A, Borrego, L. A re-assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight. CONTACT DERMATITIS. 2024; 91(3)DOI:10.1111/cod.14639. PMID:38965446. IF:4.600(Q1/1D).
01/09/2024
[Translated article] Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.
Rivera-Díaz R, Carrascosa Carrillo JM, Alfonso Zamora S, Navarro Valdivieso JP, Muñoz Cabello B, Ros Abarca S, Soria de Francisco JM, Daudén Tello E. [Translated article] Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.. Actas Dermo-Sifiliograficas. 2024; 115(8)DOI:10.1016/j.ad.2024.07.012. PMID:38972580. IF:(Q/D).
01/09/2024
Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial
Puig, L, Costanzo, A, de Jong, EMGJ, Torres, T, Warren, RB, Wapenaar, R, Wegner, S, Gorecki, P, Gramiccia, T, Jazra, M, Buyze, J, Conrad, C. Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial. Dermatology and Therapy. 2024; 14(9)DOI:10.1007/s13555-024-01245-6. PMID:39153060. IF:4.200(Q1/1D).
31/08/2024
Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
Piñana, JL, Giménez, E, Vázquez, L, Marcos, MA, Guerreiro, M, Duarte, R, Pérez, A, de Miguel, C, Espigado, I, González-Vicent, M, Suarez-Lledó, M, García-Cadenas, I, Martino, R, Cedillo, A, Rovira, M, de la Cámara, R, Navarro, D, Solano, C. Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC). Mediterranean Journal of Hematology and Infectious Diseases. 2024; 16(1)DOI:10.4084/MJHID.2024.065. PMID:39258183. IF:1.500(Q3/8D).
30/08/2024
Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment
Belvís, R, Irimia, P, González, N, García-Ull, J, Pozo-Rosich, P, López-Bravo, A, Morollón, N, Quintas, S, Plana, A, Baz, PG, Tentor, A, Artiles, NG, León, FJ, Martín, MP, Rivera, I, Ramírez, R, Colomina, I, Lainez, JM, Pascual, J. Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment. MEDICINA CLINICA. 2024; 163(4)DOI:10.1016/j.medcli.2024.02.006. PMID:38643025. IF:2.100(Q2/3D).
30/08/2024
Effect of a bundle intervention on adherence to quality-of-care indicators and on clinical outcomes in patients with Staphylococcus aureus bacteraemia hospitalized in non-referral community hospitals
Escrihuela-Vidal, F, Chico, C, González, BB, Sánchez, DV, Lerida, A, Escudero, ED, Sanmarti, M, Gonzalez, LL, Simonetti, AF, Conde, AC, Muelas-Fernandez, M, Diaz-Brito, V, Quintana, SGH, Oriol, I, Berbel, D, Camara, J, Grillo, S, Pujol, M, Cuervo, G, Carratala, J. Effect of a bundle intervention on adherence to quality-of-care indicators and on clinical outcomes in patients with Staphylococcus aureus bacteraemia hospitalized in non-referral community hospitals. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024; 79(11)DOI:10.1093/jac/dkae298. PMID:39212166. IF:3.600(Q2/3D).
30/08/2024
Colchicine in acutely decompensated heart failure: the COLICA trial
Pascual-Figal, D, Núñez, J, Pérez-Martínez, MT, González-Juanatey, JR, Taibo-Urquia, M, Llàcer-Iborra, P, Delgado, J, Villar, S, Mirabet, S, Aimo, A, Riquelme-Pérez, A, Anguita-Sánchez, M, Martínez-Sellés, M, Noguera-Velasco, JA, Ibáñez, B, Bayés-Genís, A. Colchicine in acutely decompensated heart failure: the COLICA trial. EUROPEAN HEART JOURNAL. 2024; DOI:10.1093/eurheartj/ehae538. PMID:39211951. IF:35.600(Q1/1D).
29/08/2024
Celiac disease diagnosis: transglutaminase, duodenal biopsy and genetic tests correlations
Schesquini-Roriz, KRP, Rodríguez, GMF, Castellanos, JCB, Martinez-Martinez, L, Guerrero, SB, Rodrigo, C, Badell, I. Celiac disease diagnosis: transglutaminase, duodenal biopsy and genetic tests correlations. Frontiers in Pediatrics. 2024; 12DOI:10.3389/fped.2024.1330511. PMID:39268360. IF:2.000(Q2/4D).
29/08/2024
Nutrition Users' Guides: RCTs Part 2-structured guide for interpreting and applying study results from randomised controlled trials on therapy or prevention questions
Bala, MM, Agarwal, A, Klatt, KC, Vernooij, RWM, Alonso-Coello, P, Steen, JP, Guyatt, GH, Duque, T, Johnston, BC. Nutrition Users' Guides: RCTs Part 2-structured guide for interpreting and applying study results from randomised controlled trials on therapy or prevention questions. Bmj Nutrition, Prevention & Health. 2024; DOI:10.1136/bmjnph-2023-000834. PMID:. IF:(Q/D).
28/08/2024
Skin Tau Quantification as a Novel Biomarker in Huntington's Disease
Ruiz-Barrio, I, Vázquez-Oliver, A, Puig-Davi, A, Rivas-Asensio, E, Perez-Perez, J, Fernandez-Vizuete, C, Horta-Barba, A, Olmedo-Saura, G, Salvat-Rovira, N, Sampedro, F, Vacchi, E, Melli, G, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Skin Tau Quantification as a Novel Biomarker in Huntington's Disease. MOVEMENT DISORDERS. 2024; 39(11)DOI:10.1002/mds.29989. PMID:39192729. IF:7.600(Q1/1D).
28/08/2024
First Worldwide Multicentric Series of Mini-Ecirs in Children: Outcomes from two Tertiary Endourology Centers
Quiroz, Y, Ferretti, S, Campobasso, D, Gatti, C, Caravaggi, F, Jiménez, R, Llorens, E, Bujons, A. First Worldwide Multicentric Series of Mini-Ecirs in Children: Outcomes from two Tertiary Endourology Centers. JOURNAL OF ENDOUROLOGY. 2024; 38(11)DOI:10.1089/end.2024.0168. PMID:39139074. IF:2.800(Q2/3D).
28/08/2024
Left ventricular outflow tract obstruction in Takotsubo syndrome with cardiogenic shock: prognosis and treatment
Vila-Sanjuán, S, Nuñez-Gil, IJ, Vedia, O, Corbi-Pascual, M, Salamanca, J, Martinez-Selles, M, Blanco, E, Almendro-Delia, M, Pérez-Castellanos, A, Martin-Garcia, AC, Tomasino, M, Vazirani, R, Fernández-Cordón, C, Cambra, AD, Becerra-Muñoz, VM, Guillén, M, Reyes, JA, Uribarri, A. Left ventricular outflow tract obstruction in Takotsubo syndrome with cardiogenic shock: prognosis and treatment. HEART. 2024; 110(23)DOI:10.1136/heartjnl-2024-324205. PMID:39209437. IF:4.400(Q1/3D).
27/08/2024
Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome
Zsadanyi, SE, Morcillo-Nieto, AO, Aranha, MR, Aragón, I, Arriola-Infante, JE, Vaqué-Alcázar, L, Montal, V, Pegueroles, J, Arranz, J, Rodríguez-Baz, I, Blesa, LM, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Bargallo, N, González-Ortiz, S, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Fortea, J, Carmona-Iragui, M, Bejanin, A. Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome. NEUROLOGY. 2024; 103(4)DOI:10.1212/WNL.0000000000209676. PMID:39074338. IF:8.500(Q1/1D).
27/08/2024
Antibodies in Autoimmune Neuropathies
Pascual-Goñi, E, Caballero-avila, M, Querol, L. Antibodies in Autoimmune Neuropathies. NEUROLOGY. 2024; 103(4)DOI:10.1212/WNL.0000000000209725. PMID:39088795. IF:8.500(Q1/1D).
27/08/2024
Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes
Pasquini, L, Pereira, FL, Seddighi, S, Zeng, Y, Wei, YB, Illán-Gala, I, Vatsavayai, SC, Friedberg, A, Lee, AJ, Brown, JA, Spina, S, Grinberg, LT, Sirkis, DW, Bonham, LW, Yokoyama, JS, Boxer, AL, Kramer, JH, Rosen, HJ, Humphrey, J, Gitler, AD, Miller, BL, Pollard, KS, Ward, ME, Seeley, WW. Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes. BRAIN. 2024; 147(9)DOI:10.1093/brain/awae205. PMID:38940350. IF:11.700(Q1/1D).